Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RPRX |
---|---|---|
09:32 ET | 8815 | 28 |
09:34 ET | 600 | 27.92 |
09:36 ET | 1177 | 27.915 |
09:38 ET | 1253 | 28 |
09:39 ET | 2074 | 28.02 |
09:41 ET | 3861 | 28.015 |
09:43 ET | 984 | 27.97 |
09:45 ET | 1400 | 28.01 |
09:48 ET | 7203 | 28.06 |
09:50 ET | 3640 | 28.06 |
09:52 ET | 109905 | 28.09 |
09:54 ET | 1921 | 27.99 |
09:56 ET | 1567 | 27.99 |
09:57 ET | 394 | 27.99 |
09:59 ET | 100 | 27.99 |
10:01 ET | 2351 | 27.94 |
10:03 ET | 5101 | 27.92 |
10:06 ET | 2377 | 27.93 |
10:08 ET | 2372 | 27.94 |
10:10 ET | 2600 | 27.93 |
10:12 ET | 5386 | 27.9798 |
10:14 ET | 2700 | 27.965 |
10:15 ET | 4946 | 27.965 |
10:17 ET | 2719 | 27.97 |
10:19 ET | 1700 | 27.96 |
10:21 ET | 1003 | 27.985 |
10:24 ET | 1421 | 27.985 |
10:26 ET | 1528 | 27.96 |
10:28 ET | 1000 | 27.965 |
10:30 ET | 7842 | 27.945 |
10:32 ET | 3499 | 27.945 |
10:33 ET | 1050 | 27.94 |
10:35 ET | 1466 | 27.935 |
10:37 ET | 2894 | 27.94 |
10:39 ET | 2044 | 27.905 |
10:42 ET | 2141 | 27.93 |
10:44 ET | 1737 | 27.95 |
10:46 ET | 10628 | 27.985 |
10:48 ET | 11310 | 28 |
10:50 ET | 3300 | 28 |
10:51 ET | 1479 | 27.99 |
10:53 ET | 1000 | 27.99 |
10:55 ET | 15440 | 28.005 |
10:57 ET | 4821 | 28.005 |
11:00 ET | 3503 | 28.05 |
11:02 ET | 2081 | 28.025 |
11:04 ET | 641 | 28.01 |
11:06 ET | 1693 | 28.02 |
11:08 ET | 7859 | 28.025 |
11:09 ET | 1897 | 28.005 |
11:11 ET | 4991 | 27.965 |
11:13 ET | 700 | 27.955 |
11:15 ET | 1400 | 27.95 |
11:18 ET | 1000 | 27.975 |
11:20 ET | 600 | 27.965 |
11:22 ET | 300 | 27.965 |
11:24 ET | 1253 | 27.97 |
11:26 ET | 401 | 27.985 |
11:27 ET | 405 | 27.9808 |
11:29 ET | 3979 | 27.995 |
11:31 ET | 4615 | 27.975 |
11:33 ET | 6069 | 27.975 |
11:36 ET | 13691 | 27.965 |
11:38 ET | 1600 | 27.975 |
11:40 ET | 972 | 27.965 |
11:42 ET | 5175 | 27.965 |
11:44 ET | 2765 | 27.965 |
11:45 ET | 2681 | 27.995 |
11:47 ET | 486 | 27.9986 |
11:49 ET | 1000 | 28.015 |
11:51 ET | 2216 | 27.995 |
11:54 ET | 2457 | 27.985 |
11:56 ET | 700 | 27.985 |
11:58 ET | 11761 | 28 |
12:00 ET | 2125 | 28.005 |
12:02 ET | 2997 | 27.96 |
12:03 ET | 1000 | 27.985 |
12:05 ET | 100 | 27.985 |
12:07 ET | 1029 | 27.98 |
12:09 ET | 900 | 28 |
12:12 ET | 2203 | 27.995 |
12:14 ET | 400 | 27.995 |
12:16 ET | 4142 | 27.99 |
12:18 ET | 522 | 27.995 |
12:20 ET | 3413 | 28.015 |
12:21 ET | 5246 | 28.015 |
12:23 ET | 1000 | 28.015 |
12:25 ET | 1816 | 28.015 |
12:27 ET | 626 | 28.02 |
12:30 ET | 3811 | 28.005 |
12:32 ET | 1667 | 28.015 |
12:34 ET | 1806 | 28.005 |
12:36 ET | 6031 | 27.9647 |
12:38 ET | 3507 | 27.965 |
12:39 ET | 5579 | 27.95 |
12:41 ET | 5186 | 27.9499 |
12:43 ET | 1131 | 27.945 |
12:45 ET | 4802 | 27.92 |
12:48 ET | 1332 | 27.95 |
12:50 ET | 3355 | 27.975 |
12:52 ET | 2662 | 27.97 |
12:54 ET | 100 | 27.965 |
12:56 ET | 1871 | 27.96 |
12:57 ET | 7132 | 27.945 |
12:59 ET | 751 | 27.935 |
01:01 ET | 1263 | 27.93 |
01:03 ET | 2240 | 27.935 |
01:06 ET | 3167 | 27.935 |
01:08 ET | 7608 | 27.945 |
01:10 ET | 4622 | 27.935 |
01:12 ET | 1696 | 27.9311 |
01:14 ET | 1700 | 27.93 |
01:15 ET | 2400 | 27.915 |
01:17 ET | 38766 | 27.91 |
01:19 ET | 31321 | 27.89 |
01:21 ET | 400 | 27.91 |
01:24 ET | 200 | 27.905 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Royalty Pharma PLC | 16.8B | 11.0x | +1.83% |
Amneal Pharmaceuticals Inc | 1.8B | -19.2x | --- |
Catalent Inc | 10.2B | -7.8x | --- |
Jazz Pharmaceuticals PLC | 6.9B | 18.2x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Prestige Consumer Healthcare Inc | 3.6B | -43.5x | --- |
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $16.8B |
---|---|
Revenue (TTM) | $2.4B |
Shares Outstanding | 597.4M |
Dividend Yield | 3.01% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-14-24 |
Beta | 0.46 |
EPS | $2.54 |
Book Value | $14.61 |
P/E Ratio | 11.0x |
Price/Sales (TTM) | 7.1 |
Price/Cash Flow (TTM) | 9.9x |
Operating Margin | 63.37% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.